Table 6.

Summary of Linear mixed model results of MCI and Dementia groups and by APOE ε4 status for plasma TG/HDL ratio and ApoA1, and CSF ApoA1 levels

Analyte	All MCI (n = 106)	MCI APOE4 positive (n = 58)	MCI APOE4 negative (n = 48)	All dementia (n = 50)	Dementia APOE4 positive (n = 36)	Dementia APOE4 negative (n = 14)
Plasma TG/HDL	Faster	Faster	N.S	Faster	Faster	N.S
Plasma ApoA1	Faster	Faster	Faster	Faster	Faster	Faster
CSF ApoA1	Slower	Faster	N.S	N.S	Faster	N.S

Faster: Higher baseline analyte levels relate to faster progression in one or more of the three cognitive scores: MMSE, CDR-SB, LM

Slower: Higher baseline analyte levels relate to slower progression in one or more of the three cognitive scores: MMSE, CDR-SB, LM

N.S Non-significant results